Bank of America
PTCT icon

Bank of America’s PTC Therapeutics PTCT Stock Holding History

Bank of America’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-350,000
Closed -$5.84M – 7293
2017
Q4 		$5.84M Buy
+350,000
New +$5.92M ﹤0.01% 2971
2016
Q1 		– Sell
-66,100
Closed -$2.14M – 7254
2015
Q4 		$2.14M Buy
66,100
+27,500
+71% +$809K ﹤0.01% 3743
2015
Q3 		$1.03M Buy
+38,600
New +$1.65M ﹤0.01% 4301

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America's PTCT Position: Q1 2026 in Review

Bank of America increased its PTC Therapeutics (PTCT) stake by 32% in Q1 2026, buying an estimated $32.2M and bringing the position to 1,886,841 shares worth $129M. The position accounts for 0.01% of the portfolio, ranked #956.

Bank of America first reported a position in PTCT in Q4 2013 and has held it in 50 quarters since. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Bank of America held 1,886,841 shares of PTC Therapeutics worth $129M as of Q1 2026.
  • Bank of America bought 455,284 PTC Therapeutics shares in Q1 2026, an estimated $32.2M.
  • PTC Therapeutics made up 0.01% of Bank of America's portfolio in Q1 2026, its #956 holding.
  • Bank of America first reported a position in PTC Therapeutics in Q4 2013 and has held it in 50 quarters since.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.